Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Drug Resistance

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    July 2025
  1. BATHEJA D, Saint V, Dobreva Z, Goel S, et al
    Integrating gender and equity commitments in the revised global action plan on antimicrobial resistance.
    Lancet. 2025 Jul 16:S0140-6736(25)01377-7. doi: 10.1016/S0140-6736(25)01377.
    PubMed    


    May 2025
  2. MESTROVIC T, Hsu R, Swetschinski L, Murray CJL, et al
    Global trends and projections in antimicrobial resistance - Authors' reply.
    Lancet. 2025;405:1907-1908.
    PubMed    


  3. SELVARAJ V, Sudhakar S, Sekaran S
    Global trends and projections in antimicrobial resistance.
    Lancet. 2025;405:1906-1907.
    PubMed    


  4. YANG LIU S, Long Z, Chua SL
    Global trends and projections in antimicrobial resistance.
    Lancet. 2025;405:1906.
    PubMed    


  5. FEKADU A, Woldeamanuel Y, Hailu A, Makonnen E, et al
    Global trends and projections in antimicrobial resistance.
    Lancet. 2025;405:1905-1906.
    PubMed    


  6. MA ES, Wong SC, Cheng VC, Wu P, et al
    Global trends and projections in antimicrobial resistance.
    Lancet. 2025;405:1904-1905.
    PubMed    


  7. BALASEGARAM M
    Global trends and projections in antimicrobial resistance.
    Lancet. 2025;405:1904.
    PubMed    


    April 2025
  8. MOSSIALOS E, Outterson K, Davies S, Anderson M, et al
    The antimicrobial resistance cube: a framework for identifying policy gaps and driving action.
    Lancet. 2025 Apr 30:S0140-6736(25)00674-9. doi: 10.1016/S0140-6736(25)00674.
    PubMed    


    January 2025
  9. MACESIC N, Uhlemann AC, Peleg AY
    Multidrug-resistant Gram-negative bacterial infections.
    Lancet. 2025;405:257-272.
    PubMed     Abstract available


    October 2024
  10. FORSSMED J
    Antimicrobial resistance: now is the time to revisit global commitments.
    Lancet. 2024;404:1400-1401.
    PubMed    


  11. BHATTARAI MD
    Utilising available isoniazid-resistance tests in new patients.
    Lancet. 2024;404:1403.
    PubMed    


    September 2024
  12. VAN RHIJN N, Arikan-Akdagli S, Beardsley J, Bongomin F, et al
    Beyond bacteria: the growing threat of antifungal resistance.
    Lancet. 2024;404:1017-1018.
    PubMed    


  13. WILK S, Abdul-Mutakabbir JC, Doron S, Yen C, et al
    Antimicrobial resistance in carceral settings.
    Lancet. 2024;404:1015-1016.
    PubMed    


  14. MAYHEW E, Bull A, Jayasuriya S
    Antimicrobial resistance in paediatric blast and crush injuries.
    Lancet. 2024;404:1014.
    PubMed    



  15. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
    Lancet. 2024 Sep 13:S0140-6736(24)01867-1. doi: 10.1016/S0140-6736(24)01867.
    PubMed     Abstract available


  16. KARIUKI S
    Global burden of antimicrobial resistance and forecasts to 2050.
    Lancet. 2024 Sep 13:S0140-6736(24)01885-3. doi: 10.1016/S0140-6736(24)01885.
    PubMed    


  17. CRAIG M, Jernigan D, Laserson K, McBride S, et al
    Antimicrobial resistance at a crossroads: the cost of inaction.
    Lancet. 2024 Sep 9:S0140-6736(24)01705-7. doi: 10.1016/S0140-6736(24)01705.
    PubMed    


    May 2024
  18. ADEBISI YA
    Antimicrobial resistance and people living with disabilities.
    Lancet. 2024;403:2289.
    PubMed    


  19. THE LANCET
    Antimicrobial resistance: an agenda for all.
    Lancet. 2024 May 21:S0140-6736(24)01076-6. doi: 10.1016/S0140-6736(24)01076.
    PubMed    


  20. SHAMAS N, Kariuki J, Balasa E, Kinamon T, et al
    Antimicrobial resistance survivors: calling the world to action.
    Lancet. 2024 May 20:S0140-6736(24)01030-4. doi: 10.1016/S0140-6736(24)01030.
    PubMed    


  21. LEWNARD JA, Charani E, Gleason A, Hsu LY, et al
    Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis.
    Lancet. 2024 May 20:S0140-6736(24)00862-6. doi: 10.1016/S0140-6736(24)00862.
    PubMed     Abstract available


  22. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    PubMed     Abstract available


  23. OKEKE IN, de Kraker MEA, Van Boeckel TP, Kumar CK, et al
    The scope of the antimicrobial resistance challenge.
    Lancet. 2024 May 20:S0140-6736(24)00876-6. doi: 10.1016/S0140-6736(24)00876.
    PubMed     Abstract available


  24. MENDELSON M, Lewnard JA, Sharland M, Cook A, et al
    Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach.
    Lancet. 2024 May 20:S0140-6736(24)01019-5. doi: 10.1016/S0140-6736(24)01019.
    PubMed     Abstract available


    November 2023
  25. LI P, Al-Tawfiq JA, Memish ZA, Pan Q, et al
    Preventing drug resistance: combination treatment for mpox.
    Lancet. 2023;402:1750-1751.
    PubMed    


  26. MOUSSALLY K, Abu-Sittah G, Gomez FG, Fayad AA, et al
    Antimicrobial resistance in the ongoing Gaza war: a silent threat.
    Lancet. 2023 Nov 9:S0140-6736(23)02508-4. doi: 10.1016/S0140-6736(23)02508.
    PubMed    


    September 2023

  27. A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance.
    Lancet. 2023 Sep 8:S0140-6736(23)01687-2. doi: 10.1016/S0140-6736(23)01687.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.